Global stakeholders respond to cOAlition S’s “Towards Responsible Publishing” proposal
Discover what global stakeholders thought about open access proposal “Towards Responsible Publishing” ahead of cOAlition S’s response.
A central online news resource for professionals involved in the development of medical publications and involved in publication planning and medical writing.
Discover what global stakeholders thought about open access proposal “Towards Responsible Publishing” ahead of cOAlition S’s response.
As OA publishing increases, article processing charges can price authors out. Will OA mandates also lead to issues for publishers?
Explore how increasing open access revenue signals challenges for global researchers trying to publish free-to-read articles. How can publishing move forward?
Learn about the unexpected drop in open access market share identified by Delta Think: what’s driving it, and will it continue?
Learn about planned changes to open access in Canada and their potential impact on academic research.
As US policy mandates immediate open access to all federally funded research by the end of 2025, how will this impact the publishing landscape?
Article processing charges undermine open access efforts. Are institutional open access models a better solution?
With White House policy mandating immediate open access to publicly funded research by 2025, Science journals make changes to their green open access offering.
Read about a proposed 5-part framework for strengthening the relationship between research and public policy.
Find out more about what was covered at this year’s online conference of the Open Access Scholarly Publishing Association (OASPA).
Publisher of Science journals update their Green open access policy for authors of research funded by cOAlition S organisations to allow Plan S compliance.
Learn more about this useful tool for checking compliance when publishing cOAlition S funded research articles.
Find out more about Springer Nature’s latest open access publishing options – and the concerns that some have raised.
Find out more about what was covered during the second 2021 webinar from the Center for Biomedical Research Transparency.
Find out more about the case for open access presented by Open Pharma.
Slávka Baróniková shares her opinions on open access publishing and suggests how this can be successfully achieved within pharma.